drugset / Trial / NCT00591149
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
NaSingle-groupOpen-labelTreatment
Summary
A study of Oxaliplatin and Docetaxel followed by Cetuximab for head and neck cancer patients to determine their effect on the control and reduction of tumor size
Timeline
- Start
- 2007-06
- Primary completion
- 2012-04
- Completion
- 2012-04
Outcome
Outcome not reported
Stopped (Business): “Study was stopped due to termination of funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | Intravenous |